Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever

Journal of Infectious Diseases

Volumn 183, Issue 12, 2001, Pages 1713-1721

  Mahanty, Siddhartha ^a   Bausch, Daniel G ^a   Thomas, Renee L ^a   Goba, Augustin ^b   Bah, Alpha ^b   Peters, Clarence J ^a   Rollin, Pierre E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Institut pour la Rècherche et Biologie Appliquée de Guinée   (Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; INFECTION; INFLAMMATION; LASSA FEVER; LASSA VIRUS; MAJOR CLINICAL STUDY; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; CASE-CONTROL STUDIES; CHEMOKINES, CXC; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; KINETICS; LASSA FEVER; RANTES;

EID: 0035876891     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/320722     Document Type: Article

References (39)

1. Arenaviruses
2. Pathophysiology and treatment of Lassa fever
3. A plasma inhibitor of platelet aggregation in patients with Lassa fever
4. Lassa fever encephalopathy: Clinical and laboratory findings
5. Pathologic and virologic study of fatal Lassa fever in man
6. Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted
7. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL-8 and TNF-alpha gene expression
8. Hematologic dysfunction in Lassa fever
9. Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils
10. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation
11. Soluble and cell surface receptors for tumor necrosis factor
12. Evidence for the involvement of sulfidopeptide leukotrienes in the pathogenesis of Pichinde virus infection in strain 13 guinea pigs
13. Changes in platelet-activating factor, catecholamine, and serotonin concentrations in brain, cerebrospinal fluid, and plasma of Pichinde virus-infected guinea pigs
14. Experimental studies of arenaviral hemorrhagic fevers
15. Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs
16. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever
17. Inflammatory mediators in dengue virus infection in children: Interleukin-8 and its relationship to neutrophil degranulation
18. Regulation of chemokine gene expression in human endothelial cells by proinflammatory cytokines and Borrelia burgdorferi
19. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo
20. Differential induction of interferon (IFN)-inducible protein 10 following differentiation of a monocyte: Macrophage cell lineage is related to the changes of nuclear proteins bound to IFN stimulus response element and kappaB sites
21. Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB
22. A case-control study of the clinical diagnosis and course of Lassa fever
23. Clinical, epidemiologic, and therapeutic aspects of Lassa fever
24. Lassa virus infection of rhesus monkeys: Pathogenesis and treatment with ribavirin
25. Clinical virology of Lassa fever in hospitalized patients
26. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever
27. Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling
28. Mature T lymphocyte apoptosis: Immune regulation in a dynamic and unpredictable antigenic environment
29. Soluble TNF receptors (TNF-sR55 and TNF-sR75) in lung allograft recipients displaying cytomegalovirus pneumonitis
30. Plasma levels of cytokines in primary septic shock in humans: Correlation with disease severity
31. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection
32. Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea
33. Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections
34. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
35. Lassa fever: The first confirmed case imported into Canada
36. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon
37. Regulation of lymphocyte tumor necrosis factor receptors by IL-2
38. Regulation of TNF receptors
39. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors